Trials / Completed
CompletedNCT05090748
Study for the Assessment of the Quality of Echocardiographic Clips.
A Pivotal Study for the Assessment of the Quality of Echocardiographic Clips When Obtained by Novice Users While Using the UltraSight Echocardiography Guidance (USEG) Software.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (actual)
- Sponsor
- UltraSight · Industry
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Accepted
Summary
This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, who will perform echocardiography by using UltraSight AI Guidance software, on subjects in the medical centers cardiac units.
Detailed description
This pivotal study is a multi-center, multi-reader multi-case (MRMC) study, designed to assess the quality of the clips obtained by novice users when using the UltraSight AI Guidance software. Prior to the study start, there will be a pre-study training phase for training the novice users. During the study, eligible subject will undergo the echocardiography examination twice on a single study visit (same day): once by one of the novice users when using the UltraSight AI Guidance software, and once by an expert sonographer without the aid of the software. Each novice user will perform the examination on at least 20 subjects (with the aim that the number of examinations by each novice will be similar). All examinations will be sent to multiple Board certified cardiologists for their quality evaluations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Echocardiographic. | Echocardiographic test. |
Timeline
- Start date
- 2022-05-15
- Primary completion
- 2022-08-05
- Completion
- 2022-08-31
- First posted
- 2021-10-25
- Last updated
- 2022-12-07
Locations
3 sites across 2 countries: United States, Israel
Source: ClinicalTrials.gov record NCT05090748. Inclusion in this directory is not an endorsement.